000 01250 a2200301 4500
005 20250517163543.0
264 0 _c20170907
008 201709s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2017.06.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoer, Judith M
245 0 0 _aBCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c09 2017
300 _a203-218 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
650 0 4 _aFusion Proteins, bcr-abl
_xgenetics
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xdrug therapy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aReceptors, Cytokine
_xmetabolism
700 1 _aden Boer, Monique L
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 82
_gp. 203-218
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2017.06.012
_zAvailable from publisher's website
999 _c27369075
_d27369075